Metabesity and urological cancers

Creative Commons License

ATAN A.

TURKISH JOURNAL OF UROLOGY, cilt.40, sa.4, ss.410-413, 2017 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 40 Sayı: 4
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5152/tud.2017.66502
  • Dergi Adı: TURKISH JOURNAL OF UROLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.410-413
  • Anahtar Kelimeler: Metabolic syndrome, metabesity, prostate cancer, renal cancer, RENAL-CELL CARCINOMA, BODY-MASS INDEX, METABOLIC SYNDROME, PROSTATE-CANCER, RISK-FACTOR, UNITED-STATES, OBESITY, ASSOCIATION, METAANALYSIS, COMPONENTS
  • Gazi Üniversitesi Adresli: Evet

Özet

Metabolic syndrome is one of today's most important health problems. Due to increased prevalence of metabolic syndrome in society, studies done on this topic have increased in number. Although metabolic syndrome was previously considered to be important only for cardiovascular health, it has been learned that with new data, human health is compromised more thoroughly by metabolic syndrome and is also a danger to malignancy. As a result, a new definition in the form of metabesity has been introduced. In this review, available information on metabesity and urological cancers is presented.